期刊文献+

隐丹参酮对细胞色素P450酶CYP3A4和CYP2C9的影响 被引量:6

Effects of Cryptotanshinone on CYP3A4 and CYP2C9 expressions
下载PDF
导出
摘要 目的研究丹参中脂溶性成分隐丹参酮对Chang肝脏细胞细胞色素P450酶(CYP450)CYP3A4、CYP2C9表达的影响,明确丹参主要成分对CYP450酶的作用,以阐明基于CYP450酶隐丹参酮与其他药物间相互作用的分子基础,为临床合理使用含隐丹参酮的丹参制剂提供依据。方法采用CCK-8法考察隐丹参酮对Chang肝脏细胞活力的影响,以确定药物的给药剂量范围;通过Western bloting法考察隐丹参酮在给药后1、3和7 d对Chang肝脏细胞中CYP3A4和CYP2C9蛋白表达的影响;通过定量R T-PCR法考察隐丹参酮对Chang肝脏细胞中CYP3A4和CYP2C9 mRNA表达的影响。结果给药1 d,隐丹参酮对CYP3A4蛋白及mRNA表达无显著影响。但随时间延长,给药3 d和7 d,隐丹参酮可抑制CYP3A4蛋白及mRNA的表达(P<0.05)。给药1、3和7 d,隐丹参酮对CYP2C9蛋白及mRNA的表达均无显著影响。结论连续给予隐丹参酮可抑制CYP3A4 mRNA和蛋白的表达。提示临床在连续使用含隐丹参酮时,需要关注其与CYP3A4底物药物之间可能的相互作用。 【Objective】 To investigate the effects of Cryptotanshinone on CYP3A4 and CYP2C9 expressions in Chang liver cells, confirm its effect on cytochrome P450 enzyme and analyze the drug-drug interaction so as to lay a foundation for rational medicine administration. 【Methods】 CCK-8 assay was performed to determine the proliferation of Chang liver cells after treatment with Cryptotanshinone for 1 day, 3 and 7 days.Quantificational reverse transcription polymerase chain reaction and Western blot were performed to determine mRNA and protein expressions of CYP3A4 and CYP2C9 respectively. 【Results】 After 1-day treatment, Cryptotanshinone had no effect on protein or mRNA expression of CYP3A4. However, Cryptotanshinone significantly inhibited the mRNA and protein expressions of CYP3A4(P 0.05) after 3- and 7-day treatment, and had no significant effect on the mRNA and protein expressions of CYP2C9 after 1-, 3- or 7-day treatment.【Conclusions】 Continual administration of Cryptotanshinone could inhibit the protein and mRNA expressions of CYP3A4, which suggests that the drug-drug interaction should be concerned about in clinic.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第36期1-6,共6页 China Journal of Modern Medicine
基金 国家自然科学基金(No:81373375) 上海交通大学医学院科研基金(No:14XJ10067)
关键词 隐丹参酮 Chang肝脏细胞 CYP3A4 CYP2C9 Cryptotanshinone Chang liver cell CYP3A4 CYP2C9
  • 相关文献

参考文献3

二级参考文献44

  • 1Linsel-Nitsehke P,Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov,2005 ;4: 193 -206
  • 2Ross R. Atheroselerosis-an inflammatory disease. N Engl J Med,1999 ;340 : 115-126
  • 3Blankenberg S , Barbaux S , Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis , 2003;170 : 191 -203
  • 4Kang BY, Chung SW, Kim SH, et al. Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology, 2000 ;49 ( 3 ) : 355 - 361
  • 5Chiou WF, Don MJ. Cryptotanshinone inhibits macrophage migration by impeding F-actin polymerization and filopodia extension. Life Sci,2007;81 (2): 109-114
  • 6Don M J, Liao JF, Lin LY, et al. Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the P13 K signaling pathway. Br J Pharmacol, 2007 ; 151 ( 5 ) : 638 - 646
  • 7Choi HS, Cho DI, Choi HK, et al. Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells. Arch Pharm Res, 2004 ;27 (12) : 1233 - 1237
  • 8Jin DZ, Yin LL, Ji XQ, et al. Cryptotanshinone inhibits cyclooxygenase- 2 enzyme activity but not its expression. Eur j Pharmacol,2006 ;549 ( 1 - 3 ) : 166 - 172
  • 9Zhou Z, Wang SQ, Liu Y, et al . Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells . Biochim Biophys Acla,2006 ;1760( 1 ) : 1 -9
  • 10Han JY, Fan jY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia mihiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and repeffusion. Pharmacol Ther,2008;117 (2): 280-295

共引文献25

同被引文献61

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部